Reading between the lines in the MD&A 1Q26: Syntec Construction Public Company Limited (SYNTEC)
Reading between the lines in the 1Q26 Management Discussion and Analysis of Syntec Construction Public Company Limited (SYNTEC): Revenue down 0.2%. Net profit up 1.3%. And a joint venture position that swings from loss to profit, neither filing explains why.
The numbers
Construction holds flat, accommodation slips
SYNTEC is a full-service construction contractor providing architectural, structural, and engineering services to public- and private-sector clients in Thailand, alongside a smaller accommodation services business. In 1Q26, total revenue was little changed at Bt2,059m, down 0.2% YoY. Construction revenue held flat at Bt1,939m, the largest of the two segments, while accommodation revenue fell from Bt123m to Bt118m.
Margins steady, a joint venture swing nudges net profit higher
Gross margin slipped to 14.5% in 1Q26 from 14.6% in 1Q25, with a marginal dip in construction margin largely offset by a higher accommodation margin, up to 55.8% from 55.2%. The MD&A cites a Bt4m fall in other income and a higher tax charge, offset by lower SG&A, finance costs, and a swing to profit in joint venture income. Net profit rose 1.3% YoY to Bt158m, a net margin of 7.7%.
What the numbers don’t show
Comparing the FY25 MD&A with 1Q26, this was largely a steady, template-driven quarter: both filings explain net profit through a near-identical bridge of line items, and most of the movements are fully accounted for within the filings themselves. One detail is worth noting.
A joint venture position swings from loss to profit
SYNTEC’s profit bridge includes a line for its share of joint venture results. The FY25 MD&A reported a widening loss on this line, up Bt7m for the year. Quarterly data show the loss present in every quarter of 2025.
The 1Q26 MD&A reports the same line reversing, a Bt3m increase in joint venture profit. The underlying quarterly figures show this as a swing from a Bt2m loss a year earlier to a Bt1m profit in 1Q26. Neither MD&A names the venture nor explains the reversal.